Literature DB >> 18955132

Menthol regulates TRPM8-independent processes in PC-3 prostate cancer cells.

Su-Hwa Kim1, Joo-Hyun Nam, Eun-Jung Park, Byung-Joo Kim, Sung-Joon Kim, Insuk So, Ju-Hong Jeon.   

Abstract

Menthol, a naturally occurring compound from peppermint oil, binds and activates the TRPM8 Ca(2+)-permeable channel that exhibits abnormal expression patterns in prostate cancer, suggesting that TRPM8 links Ca(2+) transport pathways to tumor biology. We thus investigated the cellular responses of prostate cancer cells to menthol. Here we found that menthol increases [Ca(2+)](i) via Ca(2+) influx mechanism(s) independent of TRPM8 in PC-3 cells. We demonstrated that menthol induces cell death at supramillimolar concentrations in PC-3 cells and the cell death is not suppressed by low extracellular Ca(2+) condition which indicates that menthol-induced cell death is not associated with Ca(2+) influx pathways. In addition, we showed that menthol increases a phosphorylated form of c-jun N-terminal kinase (JNK) in PC-3 cells through TRPM8-independent mechanisms. Thus, our data indicate that there is an apparent lack of causality between TRPM8 activation and menthol-induced cell death and that menthol can regulate TRPM8-independent Ca(2+)-transport and cellular processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955132     DOI: 10.1016/j.bbadis.2008.09.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.

Authors:  Ning Xiao; Lei M Jiang; Bo Ge; Tian Y Zhang; Xiao K Zhao; Xing Zhou
Journal:  Tumour Biol       Date:  2014-08-16

2.  Pharmacological and functional properties of TRPM8 channels in prostate tumor cells.

Authors:  Maria Valero; Cruz Morenilla-Palao; Carlos Belmonte; Felix Viana
Journal:  Pflugers Arch       Date:  2010-11-05       Impact factor: 3.657

3.  Menthol inhibits the proliferation and motility of prostate cancer DU145 cells.

Authors:  Yongzhi Wang; Xinghuan Wang; Zhonghua Yang; Guangbin Zhu; Dong Chen; Zhe Meng
Journal:  Pathol Oncol Res       Date:  2012-03-22       Impact factor: 3.201

4.  TRPM8 and prostate cancer: to overexpress or repress, that is the question-comment on "Effects of TRPM8 on proliferation and motility of prostate cancer PC-3 cells" by Yang ZH et al. in Asian Journal of Andrology.

Authors:  Prakash Kulkarni
Journal:  Asian J Androl       Date:  2009-02-23       Impact factor: 3.285

5.  Menthol Smokers: Metabolomic Profiling and Smoking Behavior.

Authors:  Ping-Ching Hsu; Renny S Lan; Theodore M Brasky; Catalin Marian; Amrita K Cheema; Habtom W Ressom; Christopher A Loffredo; Wallace B Pickworth; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-14       Impact factor: 4.254

6.  Menthol activation of corneal cool cells induces TRPM8-mediated lacrimation but not nociceptive responses in rodents.

Authors:  Ashlee Robbins; Masayuki Kurose; Barbara J Winterson; Ian D Meng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-09       Impact factor: 4.799

7.  The health effects of menthol cigarettes as compared to non-menthol cigarettes.

Authors:  Allison C Hoffman
Journal:  Tob Induc Dis       Date:  2011-05-23       Impact factor: 2.600

8.  TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.

Authors:  Swapna Asuthkar; Kiran Kumar Velpula; Pia A Elustondo; Lusine Demirkhanyan; Eleonora Zakharian
Journal:  Oncotarget       Date:  2015-07-10

9.  TRPM8 ion channels differentially modulate proliferation and cell cycle distribution of normal and cancer prostate cells.

Authors:  María Ll Valero; Fernanda Mello de Queiroz; Walter Stühmer; Félix Viana; Luis A Pardo
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 10.  Phytochemicals: a multitargeted approach to gynecologic cancer therapy.

Authors:  Lee Farrand; Se-Woong Oh; Yong Sang Song; Benjamin K Tsang
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.